Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis

por Yahya, Fariz, Gaffney, Karl, Sengupta, Raj
Publicado 2019

3. A Case of Post-Partum Auto-inflammatory Syndrome

por Owusu-Agyei, Amanda, Gaffney, Karl, Merry, Peter
Publicado 2017

Defining the target: clinical aims in axial spondyloarthritis

por Marzo-Ortega, Helena, Gaffney, Katie M, Gaffney, Karl
Publicado 2018

Prevalence of axial spondyloarthritis in patients with acute anterior uveitis: a cross-sectional study utilising MRI

por Sykes, Mark P, Hamilton, Louise, Jones, Colin, Gaffney, Karl
Publicado 2018

Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology...

por Derakhshan, Mohammad H, Dean, Linda, Jones, Gareth T, Siebert, Stefan, Gaffney, Karl
Publicado 2020

The prevalence of axial spondyloarthritis in the UK: a cross-sectional cohort study

por Hamilton, Louise, Macgregor, Alex, Toms, Andoni, Warmington, Victoria, Pinch, Edward, Gaffney, Karl
Publicado 2015

Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA

por Gaffney, Karl, Gullick, Nicola, MacKay, Kirsten, Patel, Yusuf, Sengupta, Raj, Sheeran, Tom, Hemmings, Louise, Pamies, Paula
Publicado 2023

Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMD(a)) in women with longstanding inflammatory polyarthritis: a primary care based inceptio...

por Pye, Stephen R, Marshall, Tarnya, Gaffney, Karl, Silman, Alan J, Symmons, Deborah PM, O'Neill, Terence W
Publicado 2010

Awareness of axial spondyloarthritis among chiropractors and osteopaths: findings from a UK Web-based survey

por Yong, Cee Y, Hamilton, Jill, Benepal, Jatinder, Griffiths, Katie, Clark, Zoë E, Rush, Amanda, Sengupta, Raj, Martindale, Jane, Gaffney, Karl
Publicado 2019

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit

por Russell, Mark D, Coath, Fiona, Yates, Mark, Bechman, Katie, Norton, Sam, Galloway, James B, Ledingham, Joanna, Sengupta, Raj, Gaffney, Karl
Publicado 2021

Corrigendum to: Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit

por Russell, Mark D, Coath, Fiona, Yates, Mark, Bechman, Katie, Norton, Sam, Galloway, James B, Ledingham, Joanna, Sengupta, Raj, Gaffney, Karl
Publicado 2021

Influence of Inflammatory Polyarthritis on Quantitative Heel Ultrasound Measurements

por Pye, Stephen R, Marshall, Tarnya, Gaffney, Karl, Luben, Robert, Khaw, Kay-Tee, Silman, Alan J, Symmons, Deborah PM, O’Neill, Terence W
Publicado 2012

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

por Akkoç, Nurullah, Arteaga, Carlos H., Auteri, Simone E., Betts, Marissa, Fahrbach, Kyle, Kim, Mindy, Kiri, Sandeep, Neupane, Binod, Gaffney, Karl, Mease, Philip J.
Publicado 2023

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis—findings from a United Kingdom cohort: reply

por Yahya, Fariz, Gaffney, Karl, Hamilton, Louise, Lonsdale, Ellie, Leeder, Jane, Brooksby, Alan, Cavill, Charlotte, Berry-Jenkins, Joshua, Boyle, Cathal, Bond, Debbie, Sengupta, Raj
Publicado 2018

Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational study

por Van Rossen, Liz, Chan, Antoni, Gilbert, Annie, Gaffney, Karl, Harris, Claire, Machado, Pedro M, Santos, Liliana R, Sengupta, Raj, Basset, Paul, Keat, Andrew
Publicado 2020

Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab

por Kiltz, Uta, Sfikakis, Petros P., Gaffney, Karl, Bounas, Andreas, Gullick, Nicola, Lespessailles, Eric, Brandt-Juergens, Jan, Rashkov, Rasho, Schulz, Barbara, Pournara, Effie, Jagiello, Piotr
Publicado 2022

The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease

por Müller-Ladner, Ulf, Dignass, Axel, Gaffney, Karl, Jadon, Deepak, Matucci-Cerinic, Marco, Lobaton, Triana, Carron, Philippe, Gisbert, Javier P., Pande, Ira, Utzinger, Maximilian, Addison, Janet
Publicado 2023

AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS)

por Macfarlane, Gary J., Pathan, Ejaz, Siebert, Stefan, Packham, Jonathan, Gaffney, Karl, Choy, Ernest, Sengupta, Raj, Atzeni, Fabiola, Martin, Kathryn R., Jones, Gareth T., Dean, Linda E.
Publicado 2019

Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE

por Landewé, Robert, van der Heijde, Désirée, Dougados, Maxime, Baraliakos, Xenofon, Van den Bosch, Filip, Gaffney, Karl, Bauer, Lars, Hoepken, Bengt, de Peyrecave, Natasha, Thomas, Karen, Gensler, Lianne S.
Publicado 2020

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register

por Macfarlane, Gary J, MacDonald, Ross I R, Pathan, Ejaz, Siebert, Stefan, Gaffney, Karl, Choy, Ernest, Packham, Jon, Martin, Kathryn R, Haywood, Kirstie, Sengupta, Raj, Atzeni, Fabiola, Jones, Gareth T
Publicado 2018